Cargando…

Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis

Prime-boost immunization strategies are required to control the global tuberculosis (TB) pandemic, which claims approximately 3 lives every minute. Here, we have generated an immunogenic complex against Mycobacterium tuberculosis (M.tb), consisting of promiscuous T cell epitopes (M.tb peptides) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Santosh, Bhaskar, Ashima, Patnaik, Gautam, Sharma, Chetan, Singh, Dhiraj Kumar, Kaushik, Sandeep Rai, Chaturvedi, Shivam, Das, Gobardhan, Dwivedi, Ved Prakash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934935/ https://www.ncbi.nlm.nih.gov/pubmed/33444288 http://dx.doi.org/10.1172/jci.insight.145228

Ejemplares similares

Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis
por: Negi, Kriti, et al.
Publicado: (2022)

Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

Luteolin-mediated Kv1.3 K(+) channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
por: Singh, Dhiraj Kumar, et al.
Publicado: (2020)

Correction: Luteolin-mediated Kv1.3 K(+) channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

The 1, 2-ethylenediamine SQ109 protects against tuberculosis by promoting M1 macrophage polarization through the p38 MAPK pathway
por: Singh, Mona, et al.
Publicado: (2022)

Host sirtuin 2 as an immunotherapeutic target against tuberculosis
por: Bhaskar, Ashima, et al.
Publicado: (2020)

Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases
por: Devi, Annu, et al.
Publicado: (2023)

Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis
por: Pahuja, Isha, et al.
Publicado: (2023)

Repurposing Immunomodulatory Drugs to Combat Tuberculosis
por: Fatima, Samreen, et al.
Publicado: (2021)

Reply to Levis and Rendini
por: Singh, Dhiraj Kumar, et al.
Publicado: (2017)

Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis
por: Pahuja, Isha, et al.
Publicado: (2023)

SIRT2 inhibition by AGK2 enhances mycobacteria-specific stem cell memory responses by modulating beta-catenin and glycolysis
por: Bhaskar, Ashima, et al.
Publicado: (2023)

Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
por: Verma, Akanksha, et al.
Publicado: (2022)

Withaferin A Protects against Primary and Recurrent Tuberculosis by Modulating Mycobacterium-Specific Host Immune Responses
por: Kumari, Anjna, et al.
Publicado: (2023)

Simultaneous Inhibition of T Helper 2 and T Regulatory Cell Differentiation by Small Molecules Enhances Bacillus Calmette-Guerin Vaccine Efficacy against Tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

The Phytochemical Bergenin Enhances T Helper 1 Responses and Anti-Mycobacterial Immunity by Activating the MAP Kinase Pathway in Macrophages
por: Dwivedi, Ved P., et al.
Publicado: (2017)

Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2
por: Negi, Kriti, et al.
Publicado: (2023)

Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis*
por: Rahman, Md. Aejazur, et al.
Publicado: (2015)

Expression of the ARPC4 Subunit of Human Arp2/3 Severely Affects Mycobacterium tuberculosis Growth and Suppresses Immunogenic Response in Murine Macrophages
por: Ghosh, Anamika, et al.
Publicado: (2013)

Mycobacterium tuberculosis Controls MicroRNA-99b (miR-99b) Expression in Infected Murine Dendritic Cells to Modulate Host Immunity
por: Singh, Yogesh, et al.
Publicado: (2013)

Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
por: Ahmad, Shaheer, et al.
Publicado: (2019)

Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?
por: Sharma, Abhibhav, et al.
Publicado: (2020)

Early Secreted Antigen ESAT-6 of Mycobacterium tuberculosis Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner
por: Chatterjee, Samit, et al.
Publicado: (2011)

Transforming Growth Factor-β Protein Inversely Regulates in Vivo Differentiation of Interleukin-17 (IL-17)-producing CD4(+) and CD8(+) T Cells
por: Dwivedi, Ved Prakash, et al.
Publicado: (2012)

Reducing the Activity and Secretion of Microbial Antioxidants Enhances the Immunogenicity of BCG
por: Sadagopal, Shanmugalakshmi, et al.
Publicado: (2009)

Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models
por: Tkachuk, A. P., et al.
Publicado: (2017)

Mycobacterium indicus pranii therapy induces tumor regression in MyD88- and TLR2-dependent manner
por: Kumar, Pawan, et al.
Publicado: (2019)

CD4(+) T Cell-derived Novel Peptide Thp5 Induces Interleukin-4 Production in CD4(+) T Cells to Direct T Helper 2 Cell Differentiation
por: Khan, Mohd Moin, et al.
Publicado: (2012)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

BCGΔBCG1419c increased memory CD8(+) T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis
por: Kwon, Kee Woong, et al.
Publicado: (2022)

Higher BCG‐induced trained immunity prevalence predicts protection from COVID‐19: Implications for ongoing BCG trials
por: Singh, Samer, et al.
Publicado: (2022)

Mycobacterium tuberculosis Directs T Helper 2 Cell Differentiation by Inducing Interleukin-1β Production in Dendritic Cells
por: Dwivedi, Ved Prakash, et al.
Publicado: (2012)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Molecular Analysis of Non-Specific Protection against Murine Malaria Induced by BCG Vaccination
por: Parra, Marcela, et al.
Publicado: (2013)

Express Path Analysis Identifies a Tyrosine Kinase Src-centric Network Regulating Divergent Host Responses to Mycobacterium tuberculosis Infection
por: Karim, Ahmad Faisal, et al.
Publicado: (2011)

Clofazimine enhances the efficacy of BCG revaccination via stem cell-like memory T cells
por: Ahmad, Shaheer, et al.
Publicado: (2020)

Protective Enterotoxigenic Escherichia coli Antigens in a Murine Intranasal Challenge Model
por: Kumar, Amit, et al.
Publicado: (2015)

Factors affecting immunogenicity of BCG in infants, a study in Malawi, The Gambia and the UK
por: Hur, Yun-Gyoung, et al.
Publicado: (2014)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b328mr44mlnh1c3p356j84m4gu